This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessReview
Natural Flavonoids for the Prevention of Sarcopenia: Therapeutic Potential and Mechanisms
by
Ye Eun Yoon
Ye Eun Yoon 1,*
,
Seong Hun Ju
Seong Hun Ju 1,2,
Yebean Kim
Yebean Kim 1 and
Sung-Joon Lee
Sung-Joon Lee 2,3,*
1
Department of Biotechnology, Graduate School of Biotechnology, Korea University, Seoul 02841, Republic of Korea
2
Interdisciplinary Program in Precision Public Health, BK21 Four Institute of Precision Public Health, Korea University, Seoul 02841, Republic of Korea
3
Department of Food Bioscience & Technology, Korea University, Seoul 02841, Republic of Korea
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(15), 7458; https://doi.org/10.3390/ijms26157458 (registering DOI)
Submission received: 22 June 2025
/
Revised: 29 July 2025
/
Accepted: 30 July 2025
/
Published: 1 August 2025
Abstract
Sarcopenia, characterized by progressive skeletal muscle loss and functional decline, represents a major public heath challenge in aging populations. Despite increasing awareness, current management strategies—primarily resistance exercise and nutritional support—remain limited by accessibility, adherence, and inconsistent outcomes. This underscores the urgent need for novel, effective, and scalable therapeutics. Flavonoids, a diverse class of plant-derived polyphenolic compounds, have attracted attention for their muti-targeted biological activities, including anti-inflammatory, antioxidant, metabolic, and myogenic effects. This review aims to evaluate the anti-sarcopenic potential of selected flavonoids—quercetin, rutin, kaempferol glycosides, baicalin, genkwanin, isoschaftoside, naringin, eriocitrin, and puerarin—based on recent preclinical findings and mechanistic insights. These compounds modulate key pathways involved in muscle homeostasis, such as NF-κB and Nrf2 signaling, AMPK and PI3K/Akt activation, mitochondrial biogenesis, proteosomal degradation, and satellite cell function. Importantly, since muscle wasting also features prominently in cancer cachexia—a distinct but overlapping syndrome—understanding flavonoid action may offer broader therapeutic relevance. By targeting shared molecular axes, flavonoids may provide a promising, biologically grounded approach to mitigating sarcopenia and the related muscle-wasting conditions. Further translational studies and clinical trials are warranted to assess their efficacy and safety in human populations.
Share and Cite
MDPI and ACS Style
Yoon, Y.E.; Ju, S.H.; Kim, Y.; Lee, S.-J.
Natural Flavonoids for the Prevention of Sarcopenia: Therapeutic Potential and Mechanisms. Int. J. Mol. Sci. 2025, 26, 7458.
https://doi.org/10.3390/ijms26157458
AMA Style
Yoon YE, Ju SH, Kim Y, Lee S-J.
Natural Flavonoids for the Prevention of Sarcopenia: Therapeutic Potential and Mechanisms. International Journal of Molecular Sciences. 2025; 26(15):7458.
https://doi.org/10.3390/ijms26157458
Chicago/Turabian Style
Yoon, Ye Eun, Seong Hun Ju, Yebean Kim, and Sung-Joon Lee.
2025. "Natural Flavonoids for the Prevention of Sarcopenia: Therapeutic Potential and Mechanisms" International Journal of Molecular Sciences 26, no. 15: 7458.
https://doi.org/10.3390/ijms26157458
APA Style
Yoon, Y. E., Ju, S. H., Kim, Y., & Lee, S.-J.
(2025). Natural Flavonoids for the Prevention of Sarcopenia: Therapeutic Potential and Mechanisms. International Journal of Molecular Sciences, 26(15), 7458.
https://doi.org/10.3390/ijms26157458
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.